Cipla Q1 Results FY27: Net Profit Slumps 39% to Rs 789 Crore Despite Revenue Growth; Share Price Declines

Pharmaceutical major Cipla Ltd reported a mixed set of financial results for the first quarter of FY27, as higher operating costs weighed on profitability despite the company posting modest revenue growth. The drugmaker reported a consolidated net profit of Rs 789 crore for the quarter ended June 30, 2026, marking a 39% decline from Rs 1,298 crore in the corresponding period last year.

Cipla Q1 Results: Net Profit Falls 39% to Rs 789 Crore Despite Higher Revenue

The company's revenue performance, however, remained relatively stable. Revenue from operations increased 2.3% year-on-year to Rs 7,119 crore, compared with Rs 6,957 crore reported in the June quarter of FY26. The results indicate that while demand for Cipla's products remained steady, rising costs had a significant impact on earnings during the quarter.

The biggest challenge for Cipla during the June quarter was the sharp increase in operating expenses. Total expenses rose 14.7% year-on-year to Rs 6,248 crore, considerably faster than the growth in revenue. As a result, the company's earnings came under pressure despite recording higher sales.

The increase in costs reduced overall profitability and led to a sharp fall in quarterly net profit. The company also reported earnings per share (EPS) of Rs 9.77, down from Rs 16.07 in the year-ago period, reflecting the weaker bottom-line performance.

Cipla Q1 EBITDA Falls 33%, Operating Margin Shrinks

Cipla also reported a noticeable decline in its operating performance during the quarter. EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortisation) stood at Rs 1,192 crore, down 33% from the same quarter last year. Consequently, the company's EBITDA margin narrowed to 16.7%, compared with 25.6% a year ago.

The decline in margins suggests that the company faced increased pressure from higher operating costs, which affected profitability even though revenue remained broadly stable. Although Cipla's tax expenses were lower during the quarter, the reduction was not sufficient to offset the decline in operating earnings.

Sequential Performance Shows Signs of Recovery

While the year-on-year comparison remained weak, Cipla's performance improved compared with the previous quarter.

The company reported net profit of Rs 789 crore, up from Rs 555 crore in the March quarter, while revenue from operations increased to Rs 7,119 crore from Rs 6,541 crore. The improvement indicates that business performance strengthened on a sequential basis after a relatively weaker fourth quarter.

Cipla Share Price Today

Cipla Ltd shares came under selling pressure on Thursday after the pharmaceutical major reported a weaker-than-expected performance for the June quarter (Q1 FY27), with a sharp decline in profit and operating margins.

At around 1:01 pm, Cipla shares were trading at Rs 1,385.70, down 2.08% or Rs 29.40 on the NSE. The stock opened at Rs 1,409.10, touched an intraday high of Rs 1,426.90, and slipped to a low of Rs 1,373.60 during the session as investors reacted to the quarterly numbers.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.